TransMedics Group, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
TMDX$90.95-3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income (Loss
(In thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net income (loss) | $190,291 | $35,464 | $(25,028) |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustment | 488 | (165) | 26 |
| Total other comprehensive income (loss) | 488 | (165) | 26 |
| Comprehensive income (loss) | $190,779 | $35,299 | $(25,002) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.